Fibrosis of extramacular angioid streaks following ranibizumab treatment of subfoveal choroidal neovascularization.
Bloch
Sara B
SB
Larsen
Michael
M
D000293:Adolescent; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000793:Angioid Streaks / Q000188:drug therapy* / Q000473:pathology*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005355:Fibrosis / Q000209:etiology; D005451:Fluorescein Angiography; D005584:Fovea Centralis; D006801:Humans; D058449:Intravitreal Injections; D008266:Macula Lutea / Q000473:pathology*; D000069579:Ranibizumab; D019233:Retreatment; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab